Xin Su
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Lipid metabolism and disorders
Papers in
-
- Lipid metabolism and disorders 9
- Cardiovascular Disease and Adiposity 4
- Co-authors
- Daoquan Peng (7 shared papers)Yi Wen Kong (3 shared papers)Ye Cheng (8 shared papers)Xijie Wu (3 shared papers)Dong Chang (6 shared papers)Xiang Chen (2 shared papers)Bin Wang (6 shared papers)Guo‐Ming Zhang (3 shared papers)
In The Last Decade
Xin Su
47 papers receiving 838 citations
Peers
Comparison fields: 5 of 94
- Endocrinology, Diabetes and Metabolism 208
- Cardiology and Cardiovascular Medicine 163
- Physiology 170
- Immunology 133
- Endocrine and Autonomic Systems 42
Countries citing papers authored by Xin Su
This map shows the geographic impact of Xin Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Su more than expected).
Fields of papers citing papers by Xin Su
This network shows the impact of papers produced by Xin Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Su. The network helps show where Xin Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Xin Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 92 | |
| 2 | 2009 | 71 | |
| 3 | 2022 | 67 | |
| 4 | 2018 | 57 | |
| 5 | 2019 | 55 | |
| 6 | 2016 | 46 | |
| 7 | 2020 | 41 | |
| 8 | 2021 | 36 | |
| 9 | 2019 | 31 | |
| 10 | 2019 | 30 | |
| 11 | 2022 | 26 | |
| 12 | 2020 | 25 | |
| 13 | 2021 | 24 | |
| 14 | 2020 | 23 | |
| 15 | 2021 | 21 | |
| 16 | 2021 | 16 | |
| 17 | 2021 | 16 | |
| 18 | 2000 | 15 | |
| 19 | 2014 | 13 | |
| 20 | 2020 | 11 |
About Xin Su
Xin Su is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery, having authored 48 papers that have together received 852 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers), Lipid metabolism and disorders (9 papers), Lipoproteins and Cardiovascular Health (5 papers), Cancer, Lipids, and Metabolism (4 papers), Cardiovascular Disease and Adiposity (4 papers), Cancer-related molecular mechanisms research (4 papers) and Adipose Tissue and Metabolism (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (208 citations), Cardiology and Cardiovascular Medicine (163 citations), Physiology (170 citations), Immunology (133 citations) and Endocrine and Autonomic Systems (42 citations). Xin Su has collaborated with scholars based in China and Japan. Frequent co-authors include Daoquan Peng, Yi Wen Kong, Ye Cheng, Xijie Wu, Dong Chang, Xiang Chen, Bin Wang, Guo‐Ming Zhang, Guanzhong Wu and Juan Zhang. Their work appears in journals such as Clinica Chimica Acta, Molecular Biology Reports, Current Molecular Medicine, Lipids in Health and Disease and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.